메뉴 건너뛰기




Volumn 68, Issue 1, 2013, Pages 44-51

Safety pharmacology investigations in toxicology studies: An industry survey

Author keywords

Cardiovascular; Central nervous system (CNS); Good laboratory practices (GLP); QT; Regulatory; Respiratory; S7A; S7B; Safety pharmacology; Telemetry

Indexed keywords

BIOLOGICAL PRODUCT; CHEMICAL AGENT;

EID: 84880038596     PISSN: 10568719     EISSN: 1873488X     Source Type: Journal    
DOI: 10.1016/j.vascn.2013.05.002     Document Type: Article
Times cited : (43)

References (35)
  • 1
    • 0035854839 scopus 로고    scopus 로고
    • Anon ICHS7A: Safety pharmacology studies for human pharmaceuticals
    • Anon ICHS7A: Safety pharmacology studies for human pharmaceuticals. Federal Register 2001, 66:36791-36792.
    • (2001) Federal Register , vol.66 , pp. 36791-36792
  • 3
    • 84880038157 scopus 로고    scopus 로고
    • Anon S9: Nonclinical evaluation for anticancer pharmaceuticals
    • (Docket No. FDA/2009/D/0006)
    • Anon S9: Nonclinical evaluation for anticancer pharmaceuticals. Federal Register 2010, 44:10487. (Docket No. FDA/2009/D/0006).
    • (2010) Federal Register , vol.44 , pp. 10487
  • 4
    • 84861669652 scopus 로고    scopus 로고
    • Anon S6(R1): Addendum: Preclinical safety evaluation of biotechnology-derived pharmaceuticals
    • Anon S6(R1): Addendum: Preclinical safety evaluation of biotechnology-derived pharmaceuticals. Federal Register 2012, 77:29665-29666.
    • (2012) Federal Register , vol.77 , pp. 29665-29666
  • 5
    • 35349021440 scopus 로고    scopus 로고
    • Considerations for the sensible use of rodent models of inflammatory disease in predicting efficacy of new biological therapeutics in the clinic
    • Arnett H.A., Viney J.L. Considerations for the sensible use of rodent models of inflammatory disease in predicting efficacy of new biological therapeutics in the clinic. Advances in Drug Delivery Review 2007, 59:1084-1092.
    • (2007) Advances in Drug Delivery Review , vol.59 , pp. 1084-1092
    • Arnett, H.A.1    Viney, J.L.2
  • 7
    • 34548496499 scopus 로고    scopus 로고
    • A cardiovascular monitoring system used in conscious cynomolgus monkeys for regulatory safety pharmacology. Part 2: Pharmacological validation
    • Authier S., Tanguay J.F., Gauvin D., Fruscia R.D., Troncy E. A cardiovascular monitoring system used in conscious cynomolgus monkeys for regulatory safety pharmacology. Part 2: Pharmacological validation. Journal of Pharmacological and Toxicological Methods 2007, 56:122-130.
    • (2007) Journal of Pharmacological and Toxicological Methods , vol.56 , pp. 122-130
    • Authier, S.1    Tanguay, J.F.2    Gauvin, D.3    Fruscia, R.D.4    Troncy, E.5
  • 11
    • 68549133107 scopus 로고    scopus 로고
    • Validation of a guinea pig Langendorff heart model for assessing potential cardiovascular liability of drug candidates
    • Guo L., Dong Z., Guthrie H. Validation of a guinea pig Langendorff heart model for assessing potential cardiovascular liability of drug candidates. Journal of Pharmacological and Toxicological Methods 2009, 60:130-151.
    • (2009) Journal of Pharmacological and Toxicological Methods , vol.60 , pp. 130-151
    • Guo, L.1    Dong, Z.2    Guthrie, H.3
  • 12
    • 33645059979 scopus 로고    scopus 로고
    • QT PRODACT: Usability of miniature pigs in safety pharmacology studies: Assessment for drug-induced QT interval prolongation
    • Kano M., Toyoshi T., Iwasaki S., Kato M., Shimizu M., Ota T. QT PRODACT: Usability of miniature pigs in safety pharmacology studies: Assessment for drug-induced QT interval prolongation. Journal of Pharmacological Sciences 2005, 99(5):501-511.
    • (2005) Journal of Pharmacological Sciences , vol.99 , Issue.5 , pp. 501-511
    • Kano, M.1    Toyoshi, T.2    Iwasaki, S.3    Kato, M.4    Shimizu, M.5    Ota, T.6
  • 13
    • 79953873761 scopus 로고    scopus 로고
    • Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: Translating preclinical data into new drug therapies
    • Koboziev I., Karlsson F., Zhang S., Grisham M.B. Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: Translating preclinical data into new drug therapies. Inflammatory Bowel Diseases 2011, 17(5):1229-1245.
    • (2011) Inflammatory Bowel Diseases , vol.17 , Issue.5 , pp. 1229-1245
    • Koboziev, I.1    Karlsson, F.2    Zhang, S.3    Grisham, M.B.4
  • 15
    • 77949363964 scopus 로고    scopus 로고
    • The continuing evolution of torsades de pointes liability testing methods: Is there an end in sight?
    • Lee N., Authier S., Pugsley M.K., Curtis M.J. The continuing evolution of torsades de pointes liability testing methods: Is there an end in sight?. Toxicology and Applied Pharmacology 2010, 243(2):146-153.
    • (2010) Toxicology and Applied Pharmacology , vol.243 , Issue.2 , pp. 146-153
    • Lee, N.1    Authier, S.2    Pugsley, M.K.3    Curtis, M.J.4
  • 17
    • 0035985137 scopus 로고    scopus 로고
    • Integration of safety pharmacology endpoints into toxicology studies
    • Luft J., Bode G. Integration of safety pharmacology endpoints into toxicology studies. Fundamental and Clinical Pharmacology 2002, 16(2):91-103.
    • (2002) Fundamental and Clinical Pharmacology , vol.16 , Issue.2 , pp. 91-103
    • Luft, J.1    Bode, G.2
  • 19
    • 33645059730 scopus 로고    scopus 로고
    • QT PRODACT: Sensitivity and specificity of the canine telemetry assay for detecting drug-induced QT interval prolongation
    • Miyazaki H., Watanabe H., Kitayama T., Nishida M., Nishi Y., Sekiya K., et al. QT PRODACT: Sensitivity and specificity of the canine telemetry assay for detecting drug-induced QT interval prolongation. Journal of Pharmacological Sciences 2005, 99(5):523-529.
    • (2005) Journal of Pharmacological Sciences , vol.99 , Issue.5 , pp. 523-529
    • Miyazaki, H.1    Watanabe, H.2    Kitayama, T.3    Nishida, M.4    Nishi, Y.5    Sekiya, K.6
  • 22
    • 33645065611 scopus 로고    scopus 로고
    • QT PRODACT: Comparison of non-clinical studies for drug-induced delay in ventricular repolarization and their role in safety evaluation in humans
    • Omata T., Kasai C., Hashimoto M., Hombo T., Yamamoto K. QT PRODACT: Comparison of non-clinical studies for drug-induced delay in ventricular repolarization and their role in safety evaluation in humans. Journal of Pharmacological Sciences 2005, 99(5):531-541.
    • (2005) Journal of Pharmacological Sciences , vol.99 , Issue.5 , pp. 531-541
    • Omata, T.1    Kasai, C.2    Hashimoto, M.3    Hombo, T.4    Yamamoto, K.5
  • 23
  • 28
    • 33645063232 scopus 로고    scopus 로고
    • QT PRODACT: Inter-facility variability in electrocardiographic and hemodynamic parameters in conscious dogs and monkeys
    • Sasaki H., Shimizu N., Suganami H., Yamamoto K. QT PRODACT: Inter-facility variability in electrocardiographic and hemodynamic parameters in conscious dogs and monkeys. Journal of Pharmacological Sciences 2005, 99(5):513-522.
    • (2005) Journal of Pharmacological Sciences , vol.99 , Issue.5 , pp. 513-522
    • Sasaki, H.1    Shimizu, N.2    Suganami, H.3    Yamamoto, K.4
  • 31
    • 79955713610 scopus 로고    scopus 로고
    • In silico predictions of hERG channel blockers in drug discovery: From ligand-based and target-based approaches to systems chemical biology
    • Taboureau O., Jørgensen F.S. In silico predictions of hERG channel blockers in drug discovery: From ligand-based and target-based approaches to systems chemical biology. Combinatorial Chemistry & High Throughput Screening 2011, 14(5):375-387.
    • (2011) Combinatorial Chemistry & High Throughput Screening , vol.14 , Issue.5 , pp. 375-387
    • Taboureau, O.1    Jørgensen, F.S.2
  • 32
    • 58149359018 scopus 로고    scopus 로고
    • Straight talk with. Mervyn Turner. Interview by Prashant Nair
    • Turner M. Straight talk with. Mervyn Turner. Interview by Prashant Nair. Nature Medicine 2009, 15(1):8-9.
    • (2009) Nature Medicine , vol.15 , Issue.1 , pp. 8-9
    • Turner, M.1
  • 35
    • 33747877386 scopus 로고    scopus 로고
    • Safety pharmacology assessment of drug-induced QT-prolongation in dogs with reduced repolarization reserve
    • Vormberge T., Hoffmann M., Himmel H. Safety pharmacology assessment of drug-induced QT-prolongation in dogs with reduced repolarization reserve. Journal of Pharmacological and Toxicological Methods 2006, 54:130-140.
    • (2006) Journal of Pharmacological and Toxicological Methods , vol.54 , pp. 130-140
    • Vormberge, T.1    Hoffmann, M.2    Himmel, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.